Resources

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537134/

Learn more
Editorial: Emerging Challenges in the Diagnosis and Treatment of Autoimmune Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398345/

Learn more
Encephalitis with mGluR5 antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980520/

Learn more
GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892043/

Learn more
High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772466/

Learn more
Autoimmune Encephalitis in the Intensive Care Unit February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122238/

Learn more
Coexistence of Autoimmune Encephalitis and Other Systemic Autoimmune Diseases February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834766/

Learn more
Biomarkers of Neurodegeneration in Autoimmune-Mediated Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156245/

Learn more
Autoimmune Epilepsy February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694338/

Learn more
Infection-triggered autoimmunity, The case of herpes simplex virus type 1 and anti-NMDAR antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999348/

Learn more